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Abstract
Background: Pregabalin (PG) is an anticonvulsant, analgesic and anxiolytic drug. A survey of the literature reveals
that all the reported spectrophotometric methods are either don’t offer high sensitivity, need tedious extraction
procedures, recommend the measurement of absorbance in the near UV region where interference most probably
occurs and/or use non specific reagent that don’t offer suitable linearity range.
Results: Two new sensitive and simple spectrophotometric methods were developed for determination of
pregabalin (PG) in capsules. Method (I) is based on the reaction of PG with 1,2-naphthoquinone-4-sulphonate
sodium (NQS), yielding an orange colored product that was measured at 473 nm. Method (II) is based on the
reaction of the drug with 2,4-dinitrofluorobenzene (DNFB) producing a yellow product measured at 373 nm. The
different experimental parameters affecting the development and stability of the reaction product in methods (I)
and (II) were carefully studied and optimized. The absorbance-concentration plots were rectilinear over the
concentration ranges of 2-25 and 0.5-8 μgm L
-1 for methods (I) and (II) respectively. The lower detection limits
(LOD) were 0.15 and 0.13 μgm L
-1 and the lower quantitation limits (LOQ) were 0.46 and 0.4 μgm L
-1 for methods
(I) and (II) respectively.
Conclusion: The developed methods were successfully applied to the analysis of the drug in its commercial
capsules. The mean percentage recoveries of PG in its capsule were 99.11 ± 0.98 and 100.11 ± 1.2 (n = 3).
Statistical analysis of the results revealed good agreement with those given by the comparison method. Proposals
of the reaction pathways were postulated.
Background
Pregabalin (PG) Figure 1, (S)-3-(amino methyl)-5-methyl-
hexanoic acid is lipophilic GABA (g-aminobutyric acid)
analog but it is inactive at GABAA and GABAB receptors
[1]. The main site of action of PG appears to be on the
a2δ subunit of presynaptic, voltage-dependent calcium
channels that are widely distributed throughout the per-
ipheral and central nervous system. Pregabalin binds
potently to the a2δ subunit and modulates calcium influx
at nerve terminals, and, thereby, reduces the release of
several neurotransmitters, including glutamate, nor-
adrenaline, substance P, serotonin and dopamine. These
activities and effects result in the anticonvulsant, analge-
sic and anxiolytic activity exhibited by PG. Recently,
pregabalin has been approved by the FDA for the treat-
ment of spinal cord injury and as the first drug indicated
for the treatment of fibromyalgia [2].
Pregabalin is not yet the subject of monograph in any
pharmacopeia. The literature survey revealed that few
analytical methods have been published concerning the
analysis of pregabalin in its dosage forms and biological
matrices viz, spectrophotometric [3-8], specrtofluori-
metric [3,9-11] and chromatographic [12,12-26] methods.
The chromatographic methods require high cost solvents
in addition to elaborate treatment. On the other hand,
Specrtofluorimeters are not available in many labs.
Regarding spectrophotometric methods for determina-
tion of PG, some of them don’to f f e rh i g hs e n s i t i v i t y
[5,7,8] or need tedious extraction procedures [3]. Mean-
while, some of the spectrophotometric methods recom-
mended the measurement of absorbance in the near UV
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© 2010 Walash et alregion where interference most probably occurs [4,7] or
use non specific reagent (Potassium iodide/potassium
iodate) that don’t offer suitable linearity range [6]. There-
fore, our target was to develop rapid, simple, efficient and
selective methods for the analysis of PG in pharmaceuti-
cal formulations. The proposed methods are based on
the reaction of PG through its primary amino group
either with 1,2-naphthoquinone-4-sulphonate(NQS) at
pH 10.5 or 2,4-dinitrofluorobenzene(DNFB) at pH 9.0 to
form colored reaction products peaking at 473 and
373 nm for the two methods, respectively.
The main advantages of the proposed methods are
being simple, rapid and not require tedious extraction
procedure. Compared to other reported spectrophoto-
metric methods, the proposed methods are either more
sensitive or even having comparable sensitivity.
Experimental
Instruments
- A Shimadzu UV-Visible 1601 PC Spectrophotometer
(Kyoto, Japan) was used for spectrophotometric mea-
surements (P/N 206-67001). The recording range was
0-1.0
- A Consort NV P901 digital pH Meter (Belgium) cali-
brated with standard buffers was used for checking the
pH of the buffer solutions used.
Reagents and materials
All the reagents used were of Analytical grade and dis-
tilled water is used throughout the work.
- Pregabalin pure sample was kindly provided by Pfi-
zer company (Sandwich, UK) with a purity of
100.18% as determined by the comparison method.
-L y r i c a
® capsules batch # 0744019 (labeled to con-
tain 75 mg PG each), ,product of Pfizer company,
were obtained from commercial sources in the local
Pharmacy.
- The 1,2-Naphthoquinone-4-sulphonate sodium
(Fluka chemica, USA) solution was freshly prepared
as 0.5% (w/v) aqueous solution, for method I.
- The 2,4-Dinitrofluorobenzene (Fluka chemica,
USA) solution was freshly prepared as 0.3% (v/v) in
methanol, for method II.
- Methanol, Hydrochloric acid, Borax and Boric acid
(BDH, UK).
- Borate buffer solutions (0.2 M) were prepared by
mixing appropriate volumes of 0. 2 M boric acid
with 0.2 M borax and adjusting the pH to 10.5 and
9.0 using pH Meter.
Standard Solutions
Stock solution of PG was prepared by dissolving 10.0
mg of the drug in 100 mL of distilled water. This solu-
tion was further diluted with the same solvent as appro-
priate to obtain the working concentration range. The
stock solution is stable for 7 days when kept in the
refrigerator.
General recommended procedures
Procedures for calibration graphs
i. Method I To a set of 10 mL volumetric flasks, appro-
priate aliquots of the standard working solution were
transferred, to obtain concentrations in the range
(2-25 μgm L
-1). To each flask 1 ± 0.5 mL of borate buffer
solution (pH 10.5) followed by 1.0 mL of NQS solution
(0.5%) were added and mixed well. The solutions were
heated in thermostatically controlled water bath at 55 ±
5°C for 10 min. The reaction was stopped by cooling
under tap water, and solution was completed to the
volume with distilled water. The absorbance of the result-
ing solution was measured at 473 nm against a reagent
blank prepared simultaneously. The calibration graph was
constructed by plotting the absorbance versus the final
concentration of the drug. Alternatively, the correspond-
ing regression equation was derived.
ii. Method II To a set of 10 mL volumetric flasks,
appropriate aliquots of the standard working solution
were transferred, to obtain concentrations in the range
(0.5-8 μgm L
-1). To each flask 1.5 ± 0.5 mL of borate
buffer solution (pH 9 ± 0.5) followed by 0.6 ± 0.2 mL of
DNFB solution (0.3% v/v) were added and mixed well.
The solutions were heated in thermostatically controlled
water bath at 70 ± 10°C for 20 min. The reaction was
stopped by cooling under tap water, and then 0.2 mL of
HCl was added and the solutions were made up to
volume with distilled water. The absorbance was mea-
sured at 373 nm against a reagent blank. The absor-
bance was plotted versus the final concentration of the
drug to obtain the calibration graph. Alternatively, the
corresponding regression equation was derived.
Assay procedure for capsules
The contents of the ten Lyrica
® capsules were emptied,
weighed and then mixed well. A weighed quantity of the
Figure 1 Structural formula of Pregabalin (PG).
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Page 2 of 10powder equivalent to 40.0 mg PG was transferred into
100 mL conical flask, extracted with 3 X 30 mL of dis-
tilled water and filtered if needed into 100 mL volu-
metric flask and the solution was completed to 100 mL
with distilled water to prepare a stock solution of
400 μgm L
-1. This solution was further diluted with the
same solvent as appropriate to obtain the working con-
centration range. Aliquots covering the working concen-
tration ranges (8, 15 and 20 μgm L
-1 for Method I and
3,4 and 6 μgm L
-1 for Method II) were transferred into
as e r i e so f1 0m Lv o l u m e t r i cf l a s k sa n dt h ep r o c e d u r e s
under the two methods were applied. The nominal con-
tent of the capsules was determined using the corre-
sponding regression equations or the calibration graphs.
Results and Discussion
Pregabalin has no specific absorbance since it is aliphatic
compounds and devoids of any chromophores or aux-
chromes which are essential for light absorption. How-
ever, a spectrophotometric method was reported for the
determination of PG based on the direct measurement of
the absorbance at lmax 210 nm (4). In contrast, other
repots (7, 10) confirmed that, the drug has no specific
absorbance in the UV-region. This renders its spectro-
photometric determination a challenging problem. Such
problem is highly aggravated when it is necessary to
determine the drug especially in pharmaceutical prepara-
tions. However, aliphatic nature of PG and presence of a
primary amino group which is susceptible to derivitaza-
tion with nucleophilic reagents such as NQS or DNFB
initiated the present study.
1,2-naphthoquinone-4sulphonate sodium has been
used as chromogenic and fluorogenic reagent for the
analysis of many pharmaceutical primary and secondary
amines [27-29]. However, its reaction with PG has not
been yet investigated. Therefore, the present study was
devoted to explore NQS as a derivatizing reagent for the
development of spectrophotometric method for the
determination of PG in its capsules. NQS was found to
react with PG in borate buffer of pH 10.5 yielding a
highly colored orange reaction product which exhibit
maximum absorbance at 473 nm (Figure 2).
The analytical applications of 2,4-dinitrofluorobenzene
(DNFB) for the assay and characterization of specific
functional groups such as primary and secondary
amines, phenols, thiols and imidazoles have been
reported by Connor [30,31]. In the present work DNFB
reacts through a nucleophilic aromatic substitution reac-
tion with the primary aliphatic amino group of PG in
aqueous alkaline medium. The reaction between PG and
DNFB is very slow at room temperature and required
heating to accelerate it. A yellow colored reaction pro-
duct peaking at 373 nm is produced (Figure 2).
Study of Experimental Parameters
The experimental conditions were established by varying
each in turn while keeping all others constant. These
variables include; effect of pH and volume of buffer,
effect of the concentration of reagents, effect of heating
temperature and heating times, effect of diluting solvent
and effect of time on stability of the reactions products.
i. Effect of pH and volume of buffer
The influence of pH on the formation of the reactions
products was studied over the range of 6.0-12.0 using
0.2 M borate buffer solution. Maximum and constant
absorption intensities were achieved at pH 10.5 ±
0.5 for Method I and 9.0 ± 0.5 for Method II. Therefore,
pH 10.5 and 9.0 were chosen as the optimum pH values
for Methods I and II, respectively (Figure 3).
Maximum absorbance intensities were achieved using
0.8-1.5 mL or 1.0-2.0 mL of borate buffer solutions for
Methods I and II, respectively (Figure 4). So that, 1.0 mL
of borate buffer solution of pH 10.5 and 1.5 mL of borate
buffer solution of pH 9.0 were chosen as the optimum
buffer volumes for Methods I and II, respectively.
ii. Effect of the concentration of reagents solutions
The influence of the reagents concentration was studied
using different volumes of either 0.5% w/v solution of
NQS (Method I) or 0.3% v/v solution of DNFB (Method
II). It was found that, increasing volumes of the reagents
produced a proportional increase in the absorbance values.
Maximum absorbencies were achieved using volumes of
the reagents ranged from 0.7-2.0 or 0.4-1.0 mL of NQS or
DNFB for Methods I and II, respectively. Further increase
Figure 2 Absorption spectra of (a) NQS 0.5%(w/v) in water
(method I). (b) PG (25 μgm L
-1) with NQS (method I). (c) DNFB
0.3%(w/v) in methanol (method II). (d) PG (6 μgm L
-1) with DNFB
(method II).
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Page 3 of 10of the reagents volume produced a gradual decrease in the
absorption intensity. Therefore, 1 mL of 0.5% w/v NQS
solution and 0.6 mL of 0.3% v/v DNFB solution were cho-
sen as the optimal volumes of the reagents for Methods I
and II, respectively (Figure 5). For Method II, to remove
the excess DNFB reagent interference in the absorbance
measurement of the reaction product, this excess was
acid-hydrolyzed to colorless 2,4-dinitrophenol by adding
0.2 mL of HCl allowing the measurement of PG-DNFB
derivative which remains stable.
iii. Effect of temperature and heating time
The effect of the heating temperatures on the formation
of the reactions products was studied using a thermosta-
tically controlled water bath at different temperature
settings ranging from (30-100 °C). For both methods,
the results revealed that increasing the temperature
resulted in an increase in the absorbance values of the
reactions products. The maximum absorbance values
were attained at 50-60 and 60-80 ° C for Methods I and
II, respectively. At higher temperatures, the absorbance
of the reaction product decreased gradually in case of
Method I, on the other hand slight decrease of the
absorbance occurred in case of Method II (Figure 6).
The decrease in the absorbance was probably attributed
to the instability of the PG derivatives at higher tem-
peratures. Therefore, the studies were carried out at 55
and 70°C for Methods I and II, respectively.
The effect of heating times on the formation of the
reactions products were investigated at different time
intervals. The results revealed that, for Method I, com-
plete reaction was achieved within 10 min and further
increase in the reaction time did not affect the absor-
bance intensity (Figure 7). Regarding Method II, the
reaction went to completion within 20 min, and longer
reaction times up to 25 min did not affect the absor-
bance intensity. On the other hand, heating for 30 min
resulted in slight decrease in absorbance intensity. So
that, 20 min was selected as the optimum reaction time
for Method II (Figure 7).
Figure 3 Effect of the pH of 0.2 M borate buffer on the
absorbance of the reaction product of PG of PG with NQS or
DNFB.
Figure 4 Effect of the volume of 0.2 M borate buffer on the
absorbance of the reaction product of PG with NQS or DNFB.
Figure 5 Effect of the volume of reagent on the absorbance of
the reactions products of PG with NQS or DNFB.
Figure 6 Effect of the temperature on the on the absorbance
of the reactions products of PG with NQS or DNFB.
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Page 4 of 10iv. Effect of diluting solvent
The effect of diluting solvents on the absorbance inten-
sities of the reactions products was tested using different
solvents viz water, methanol, acetone, acetonitrile and
dimethylformamide. Using water as diluting solvent gave
the highest absorbance values and best peaks shapes.
Water was chosen finally as the best diluting solvent for
the two methods.
v. Effect of time on stability of the reactions products
Regarding the stability of the produced derivatives, both
were found to be stable at room temperature for
approximately 2 hour.
Validation of the proposed Methods
The validity of the proposed methods was tested regarding
linearity, specificity, accuracy, repeatability and intermedi-
ate precision according to ICH Q2(R1) recommendations
[32].
Linearity
The calibration graphs obtained by plotting the values of
the absorbance versus the final concentration of the
drug (μgm L
-1) were found to be rectilinear over the
concentration ranges cited in Table 1. The proposed
methods were evaluated for the accuracy as percent
relative error (% Er) and the precision as percent relative
standard deviation (% RSD) (Tables 1 and 2).
T h ev a l i d i t yo ft h em e t h o d sw e r ep r o v e db ys t a t i s t i c a l
evaluation of the regression data, regarding the standard
deviation of the residuals (Sy/x), the standard deviation
of the intercept (Sa) and standard deviation of the slope
(Sb). The results are abridged in
Table 1. The small values of the figures indicate low
scattering of the points around the calibration line and
high precision.
Limit of quantitation and limit of detection
The limits of quantitation (LOQ) were determined by
establishing the lowest concentration that can be
measured according to ICH Q2(R1) recommendation
[32] below which the calibration graph is non linear.
The results are shown in Table 1. The limits of detec-
tion (LOD) were determined by evaluating the lowest
concentration of the analyte that can be readily detected.
The results are also summarized in Table 1.
LOQ and LOD were calculated according to the fol-
lowing equations [32]:
LOQ = 10 Sa/b
LOD = 3.3 Sa/b
Where Sa is the standard deviation of the intercept of
regression line, and b is the slope of the regression line.
Accuracy
To test the validity of the proposed methods they were
applied to the determination of pure sample of PG
over the concentration ranges cited in Table 1. The
results obtained were in good agreement with those
obtained using the comparison method. Statistical ana-
lysis of the result obtained using student t-test and the
variance ratio F-test [33] revealed no significance dif-
ferences between the proposed and comparison meth-
ods regarding the accuracy and precision, respectively
(Table 2). The spectrophotometric comparison method
[3] is based on the derivitization of PG with7-chloro-4-
nitrobenzofurazon (NBD-Cl) [3]. The absorbance of
the reaction product was measured at 460 nm and the
concentration was rectilinear over the concentration
range 0.5-7.0 μgm L
-1.
Precision
i. Repeatability (intra-day) The repeatability was per-
formed over the specific concentration range through
replicate analysis of three concentrations of PG in pure
Figure 7 Effect of the heating time on the on the absorbance
of the reactions products of PG with NQS or DNFB.
Table 1 Performance data for the proposed methods
Parameter Method I Method II
Concentration range (μgm L
-1) 2.0-25.0 0.5-8.0
Limit of detection (LOD) (μgm L
-1) 0.15 0.13
Limit of quantification (LOQ) (μgm L
-1) 0.47 0.39
Correlation coefficient (r) 0.9999 0.9999
Slope 0.0352 0.107
Intercept -0.0116 0.0203
Sy/x 0.003 0.005
Sa 0.002 0.004
Sb 0.0001 0.0009
%RSD 1.35 1.10
% Error 0.51 0.45
ε (l/mol./cm.) 5604 17034
Where:
Sy/x: Standard deviation of the residuals
Sb: Standard deviation of the slope
% Error = % RSD/√n
Sa: Standard deviation of the intercept
ε: Molar absorptivity
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Page 5 of 10Table 2 Application of the proposed and comparison methods to the determination of PG in pure form
Parameter Method I Method II Comparison Method [3]
Conc. Taken (μgm L
-1) Conc. Found (μgm L
-1) % Found Conc. Taken (μgm L
-1) Conc. found (μgm L
-1) % Found % Found
2.00 2.05 102.50 0.50 0.50 100.00
3.00 3.02 100.67 2.00 1.96 98.00 100.89
5.00 4.90 98.00 3.00 3.00 100.00 100.68
12.00 12.02 100.17 4.00 4.02 100.50 98.62
15.00 14.95 99.67 6.00 6.07 101.17 100.51
20.00 20.08 100.40 8.00 7.94 99.25
25.00 24.93 99.72
X±S.D. 100.16 ± 1.35 99.82 ±1.09 100.18 ± 1.05
T 0.02 (2.26)
a 0.51 (2.31)
a
F 1.65 (8.94)
a 1.09 (9.01)
a
Each result is the average of three seperete determinations.
a_Values between brackets are the tabulated t and F values, at p = 0.05 [33].
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0form on three successive occasions. The results are pre-
sented in Table 3.
ii. Intermediate precision (inter-day) Intermediate pre-
cision was tested by repeated analysis of PG in pure
form using the concentrations shown in Table 3 for a
period of 3 successive days. The results are summarized
in Table 3.
High % recovery, low SD and low % RSD indicate high
accuracy and precision of the proposed method respec-
tively (Table 4).
Robustness of the method
The robustness of the procedures adopted in the two pro-
posed method was demonstrated by the constancy of the
absorbance intensity with the deliberated minor changes
in the experimental parameters. For Method I, the changes
included the pH of borate buffer solution, 10.5 ± 0.5, the
change in the volume of the buffer solution, 1.0 ± 0.5 mL,
the change in the volume of NQS (0.5% w/v), 1.0 ± 0.3,
the change in the heating temperature, 55 ± 5°C and the
change in the heating time, 10 ± 2 min. Meanwhile, for
method II these changes included the pH of borate buffer
solution, 9.0 ± 0.5, the change in the volume of the buffer
solution, 1.5 ± 0.5 mL, the change in the volume of DNFB
(0.3% v/v), 0.6 ± 0.2 mL, the change in the heating tem-
perature, 70 ± 10 °C and the change in the heating time,
20 ± 2 min. These minor changes that may take place dur-
ing the experimental operation didn’t affect the absor-
bance of the reactions products.
Selectivity
The Selectivity of the methods was investigated by
observing any interference encountered from the
common capsule excipients, such as lactose monohy-
drate, corn starch and talc. These excipients did not
interfere with the proposed methods.
Pharmaceutical Applications
The proposed methods were successfully applied to the
determination of the studied drug in its pharmaceutical
preparations. The results obtained were statistically
compared to those of the comparison method [3] using
Student’s t-test for accuracy and the variance ratio F-
test for precision respectively (Table 4). The results
obtained indicate no significance difference between the
proposed methods and the comparison one.
Molar ratio and mechanism of the reaction
The stoichiometry of the reactions in the two methods
was studied adopting the limiting logarithmic method
[34]. The two straight lines were obtained using increas-
ing concentrations of the reagent while keeping the con-
centration of the drug constant and using increasing
concentrations of the drug while keeping the concentra-
tion of the reagent constant. Plots of log absorbance ver-
sus log [NQS] and log [PG] gave two straight lines, the
slopes of which were 0.93 and 1.05 for NQS and PG,
respectively (Figure 8). Hence, It is concluded that the
reaction proceeds in the ratioo f1 : 1 ,c o n f i r m i n gt h a t
one molecule of the drug condenses with one molecule
of NQS.
For Method II the determination of the stoichiometry
of the reaction of PG and DNFB was performed simi-
larly. Plots of log absorbance versus log[DNFB] and log
Table 3 Validation of the proposed methods for the determination of PG pure form
Parameter Method I Method II
Pregabalin concentration (μgm L
-1 ) Pregabalin concentration (μgm L
-1 )
8.0 15.0 20 2 4 6
Intraday
% Found 100.37 100.77 100.76 98.72 101.75 98.34
101.23 98.20 101.02 101.29 98.24 100.89
98.94 101.80 99.24 101.43 99.72 101.48
Mean (x) 100.18 100.26 100.34 100.48 99.90 100.24
S.D. 1.16 1.85 0.96 1.53 1.76 1.67
% RSD 1.16 1.85 0.96 1.52 1.76 1.67
% Error 0.67 1.07 0.55 0.88 1.02 0.96
Inter-day
% Found 100.47 99.09 100.32 99.37 98.90 102.26
99.53 101.48 99.71 100.63 101.10 100.75
100.78 100.91 101.16 98.95 101.10 99.25
Mean (x) 100.26 100.49 100.40 99.65 100.37 100.75
S.D. 0.65 1.25 0.73 0.87 1.27 1.51
% RSD 0.65 1.24 0.73 0.88 1.27 1.49
% Error 0.38 0.72 0.42 0.51 0.73 0.86
Each result is the average of three separate determinations.
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Page 7 of 10[PG] gave straight lines, the values of their slopes were
0.77 for DNFB and 0.89 for PG (Figure 8). Hence, it is
concluded that the reaction proceeds in the ratio of 1:1,
confirming that one molecule of the drug condenses
with one molecule of DNFB.
Based on the obtained molar ratios and in analogy to
previous studies (19, 23) reactions pathways are postu-
lated to proceed as shown in schemes 1 and 2,
respectively.
Conclusions
The proposed spectrophotometric methods provided
sensitive, specific and inexpensive analytical procedures
for determination of the non-chromophoric drug PG
either per se or in its capsule dosage forms without
interference from common excipients. Moreover, the
developed methods are less time-consuming and do not
require elaborate treatments associated with chromato-
graphic methods. Moreover, the reagents used are non-
irritant in contrast for NBD-Cl which cause high irritant
effect to the skin these attributes, in addition to the
satisfactory sensitivity and reproducibility as well as the
convenience and simplicity, make the two proposed
methods suitable for routine analysis in quality control
laboratories.
Table 4 Application of the proposed and comparison methods to the determination of PG in capsule dosage form
Pharmaceutical preparation Method I Method II Comparison method [3]
Conc. taken (μgm L
-1) % Found Conc. taken (μgm L
-1) % Found
Lyrica
® Capsules 8.0 99.91 3.0 100.45 101.01
(75 mg PG/capsule)
b 15.0 99.41 4.0 101.11 99.43
20.0 98.01 6.0 98.78 99.3
X±S.D. 99.11 ± 0.98 100.11 ± 1.20 99.91 ± 0.95
T 1.016 (2.776)
a 0.226 (2.776)
a
F 1.070 (19.00)
a 1.591 (19.00)
a
Nominal content of capsule(75 mg) 74.33 ± 0.74 74.08 ± 0.90
Each result is the average of three separate determinations.
a Values between brackets are the tabulated t and F values, at p = 0.05 [33].
b Product of Pfizer (Batch No: 0744019 and Exp date: 10/2010)
Figure 8 Limiting logarithmic plots for the molar reactivity of
PG with the two proposed reagents. (A) log A vs log [reagent]
with [PG] kept constant; (B) log A vs log [PG] with [reagent] kept
constant.
Scheme 1 Proposed reaction pathway between NQS and PG under
the described reaction conditions.
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